Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Bujanda

Showing results (321-330 of 423) with videos related to

Pageof 43
Sort By:
Cancers|February 11, 2023
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry StudyIvan Guerra, Luis Bujanda, Miriam Mañosa, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)María José García, Sabino Riestra, Aurelien Amiot, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2026
Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumabPatricia de Castro-Martínez, Luis G Guijarro, Jorge Monserrat, et al.
Biomedicines|March 25, 2022
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease SeverityLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
Gastroenterology|January 29, 2013
Risk of cancer in cases of suspected lynch syndrome without germline mutationMaría Rodríguez-Soler, Lucía Pérez-Carbonell, Carla Guarinos, et al.
Gastrointestinal Endoscopy|December 11, 2012
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopiesRodrigo Jover, Pedro Zapater, Eduardo Polanía, et al.
Journal of Hepatology|February 27, 2017
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinomaMaite Merino-Azpitarte, Elisa Lozano, María J Perugorria, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Gastroenterology|April 13, 2017
Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree RelativesCecilia Egoavil, Miriam Juárez, Carla Guarinos, et al.
Pageof 43

Showing results (321-330 of 423) with videos related to

Sort By:
Pageof 43
Cancers|February 11, 2023
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry StudyIvan Guerra, Luis Bujanda, Miriam Mañosa, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)María José García, Sabino Riestra, Aurelien Amiot, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2026
Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumabPatricia de Castro-Martínez, Luis G Guijarro, Jorge Monserrat, et al.
Biomedicines|March 25, 2022
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease SeverityLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
Gastroenterology|January 29, 2013
Risk of cancer in cases of suspected lynch syndrome without germline mutationMaría Rodríguez-Soler, Lucía Pérez-Carbonell, Carla Guarinos, et al.
Gastrointestinal Endoscopy|December 11, 2012
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopiesRodrigo Jover, Pedro Zapater, Eduardo Polanía, et al.
Journal of Hepatology|February 27, 2017
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinomaMaite Merino-Azpitarte, Elisa Lozano, María J Perugorria, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Gastroenterology|April 13, 2017
Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree RelativesCecilia Egoavil, Miriam Juárez, Carla Guarinos, et al.
Pageof 43